Riskpilot← Back to searchSign inGet full accessØREKLINIKKEN I/S
I/SActiveCVR 51399617Merkurvej 1K, 2.Medical specialists activities · NACE 8622Est. 19759 employees
Revenue 2025
DKK 8,2M
-1% vs 2024
EBITDA margin
52.1%
-5% vs 2024
Equity ratio
56.3%
Financial strength
Net profit 2025
DKK 4,1M
-1% vs 2024
| Revenue | DKK 8,2M | -1% |
| EBITDA | DKK 4,3M | -5% |
| Net profit | DKK 4,1M | -1% |
| Total assets | DKK 1M | -26% |
| Equity | DKK 589K | +23% |
| Employees | 9 | — |
Legal name
ØREKLINIKKEN I/S
CVR number
51399617
Legal form
Interessentskab
NACE code
8622 · Medical specialists activities
Founded
1. marts 1975
Share capital
—
Employees
9 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes i forening af interessenterne
Company purpose
Virksomhedens formål er at drive øreklinik
Address
Merkurvej 1K, 2.
Email
entHerning@mail.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7.248 | 7.586 | 8.387 | 8.276 | 8.208 |
| Staff expenses | -3.099 | -2.972 | -3.328 | -3.771 | -3.932 |
| EBITDA | 4.149 | 4.613 | 5.059 | 4.501 | 4.275 |
| Depreciation & amort. | -404 | -331 | -404 | -351 | -162 |
| EBIT | 3.745 | 4.283 | 4.655 | 4.150 | 4.114 |
| Net financials | -65 | -66 | -68 | -14 | -6 |
| Profit before tax | 3.679 | 4.217 | 4.588 | 4.135 | 4.108 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 3.679 | 4.217 | 4.588 | 4.135 | 4.108 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1.561 | 1.625 | 1.580 | 1.406 | 1.046 |
| Equity | -2.272 | -940 | 762 | 481 | 589 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3.833 | 2.564 | 818 | 925 | 456 |
| Total debt | 3.833 | 2.564 | 818 | 925 | 456 |
EBITDA margin
52.1%
This company
15.8%
Market median
+230% vs market
20212025
Equity ratio
56.3%
This company
38.2%
Market median
+47% vs market
20212025
Return on equity
697.1%
This company
18.4%
Market median
+3689% vs market
20212025
Net profit margin
50.0%
This company
8.1%
Market median
+517% vs market
20212025
Asset turnover
7.85×
This company
1.12×
Market median
+601% vs market
20212025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EN Management | Management | 2021 |
CL Management | Management | 2021 |
| Former (5) | ||
VK Stakeholder | Stakeholder | 1975 – 2004 |
HA Stakeholder | Stakeholder | 2003 – 2007 |
AT Stakeholder | Stakeholder | 2003 – 2008 |
KB Stakeholder | Stakeholder | 2013 – 2016 |
LC Stakeholder | Stakeholder | 1975 – 2012 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ØREKLINIKKEN I/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vagn Kolze | Stakeholder | 0 companies |
| Henning Anker Rode Lindeberg | Stakeholder | 0 companies |
| Arne Toft Ravn Pedersen | Stakeholder | 0 companies |
| Katrine Bernsdorf | Stakeholder | 0 companies |
| Leif Clausen | Stakeholder | 0 companies |
| Eddie Normann Nielsen | Management | 0 companies |
| Christian Lindhardt | Management | 0 companies |